IMPA2 and cervical carcinoma: Our results (Figure 5) also suggest that paclitaxel can kill tumor cells by regulating the expression of IMPA2/AIFM2, and this mechanism provides a new target for the major role of paclitaxel as an anti-cervical cancer drug in cancer chemotherapy.